Anti-inflammatory compounds of plant origin. Part II. modulation of pro-inflammatory cytokines, chemokines and adhesion molecules, Planta Med, vol.70, pp.93-103, 2004. ,
Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor kappa B (NF-kappaB), Planta Med, vol.69, pp.973-983, 2003. ,
Ready for a comeback of natural products in oncology, Biochem Pharmacol, vol.77, pp.1447-1457, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-00493481
Hyperforin: more than an antidepressant bioactive compound?, Life Sci, vol.79, pp.105-111, 2006. ,
Hyperforin, a new lead compound against the progression of cancer and leukemia, Leukemia, vol.20, pp.1519-1525, 2006. ,
Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations, Aaps J, vol.11, pp.710-727, 2009. ,
Neurobiological effects of Hyperforin and its potential in Alzheimer's disease therapy, Curr Med Chem, vol.17, pp.391-406, 2010. ,
Hyperforin is a novel type of 5-lipoxygenase inhibitor with high efficacy in vivo, Cell Mol Life Sci, vol.66, pp.2759-2771, 2009. ,
wort: biomedical research catches up with folk medicine, Clin Chim Acta, vol.381, pp.69-77, 2007. ,
Mechanisms of Hyperforin as an anti-angiogenic angioprevention agent, Eur J Cancer, vol.45, pp.1474-1484, 2009. ,
Hyperforin and aristoforin inhibit lymphatic endothelial cell proliferation in vitro and suppress tumor-induced lymphangiogenesis in vivo, Int J Cancer, vol.125, pp.34-42, 2009. ,
Hyperforin a constituent of St John's wort (Hypericum perforatum L.) extract induces apoptosis by triggering activation of caspases and with hypericin synergistically exerts cytotoxicity towards human malignant cell lines, Eur J Pharm Biopharm, vol.56, pp.121-132, 2003. ,
Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway, Chem Biol Interact, vol.190, pp.91-101, 2011. ,
Proapoptotic properties of hyperforin in leukemic cells from patients with B-cell chronic lymphocytic leukemia, Leukemia, vol.20, pp.491-497, 2006. ,
Noxa upregulation is associated with apoptosis of chronic lymphocytic leukemia cells induced by hyperforin but not flavopiridol, Leukemia, vol.23, pp.594-596, 2009. ,
Recent developments in acute myelogenous leukemia therapy, Oncologist, vol.12, issue.2, pp.14-21, 2007. ,
The immunophenotype of acute myeloid leukemia: is there a relationship with prognosis?, Blood Rev, vol.20, pp.71-82, 2006. ,
Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience, Cancer, vol.112, pp.572-580, 2008. ,
Flavopiridol: pleiotropic biological effects enhance its anticancer activity, Anticancer Drugs, vol.15, pp.411-419, 2004. ,
Pathways to caspase activation, Cell Biol Int, vol.29, pp.489-496, 2005. ,
Drug-induced Myc-mediated apoptosis of cancer cells is inhibited by stress protein Hsp70, Int J Cancer, vol.121, pp.2615-2621, 2007. ,
Mechanism and functional role of XIAP and Mcl-1 down-regulation in flavopiridol/vorinostat antileukemic interactions, Mol Cancer Ther, vol.6, pp.692-702, 2007. ,
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo, Blood, vol.113, pp.4656-4666, 2009. ,
Bid Stands at the Crossroad of Stressresponse Pathways, Curr Cancer Drug Targets, vol.10, pp.584-592, 2010. ,
Phosphoinositide 3-kinase/Akt signaling pathway and its therapeutical implications for human acute myeloid leukemia, Leukemia, vol.20, pp.911-928, 2006. ,
Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias, Leukemia, vol.18, pp.267-275, 2004. ,
Cellular survival: a play in three Akts, Genes Dev, vol.13, pp.2905-2927, 1999. ,
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms, Blood, vol.104, pp.509-518, 2004. ,
Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells, Mol Pharmacol, vol.73, pp.1549-1557, 2008. ,
Targeting NF-kappaB in hematologic malignancies, Cell Death Differ, vol.13, pp.748-758, 2006. ,
Retinoid-induced activation of NF-kappaB in APL cells is not essential for granulocytic differentiation, but prolongs the life span of mature cells, Oncogene, vol.24, pp.7145-7155, 2005. ,
Differential modulation of apoptosis sensitivity in CD95 type I and type II cells, J Biol Chem, vol.274, pp.22532-22538, 1999. ,
Bid: a Bax-like BH3 protein, Oncogene, vol.27, issue.1, pp.93-104, 2008. ,
Loss of the Bcl-2 phosphorylation loop domain is required to protect human myeloid leukemia cells from flavopiridol-mediated mitochondrial damage and apoptosis, Cancer Biol Ther, vol.1, pp.136-144, 2002. ,
Induction of apoptosis by esculetin in human leukemia U937 cells through activation of JNK and ERK, Toxicol Appl Pharmacol, vol.227, pp.219-228, 2008. ,
Targeted induction of apoptosis for cancer therapy: current progress and prospects, Trends Mol Med, vol.12, pp.382-393, 2006. ,
Noxa: at the tip of the balance between life and death, Oncogene, vol.27, issue.1, pp.84-92, 2009. ,
Roles and Regulation of the Transcription Factor CREB in Pancreatic b-Cells, Curr Mol Pharmacol, 2011. ,
Cell survival, cell death and cell cycle pathways are interconnected: implications for cancer therapy, Drug Resist Updat, vol.10, pp.13-29, 2007. ,
Physiological regulation of Akt activity and stability, Am J Transl Res, vol.2, pp.19-42, 2010. ,
independent NOXA induction overcomes apoptotic resistance of malignant melanomas, Mol Cancer Ther, vol.3, pp.895-902, 2004. ,
Microarray analysis reveals that TP53-and ATM-mutant B-CLLs share a defect in activating proapoptotic responses after DNA damage but are distinguished by major differences in activating prosurvival responses, Blood, vol.103, pp.291-300, 2004. ,
Nuclear phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3-kinase, Akt, and PTen: emerging key regulators of anti-apoptotic signaling and carcinogenesis, Eur J Histochem, vol.51, issue.1, pp.125-131, 2007. ,
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML, Blood, vol.109, pp.3509-3512, 2007. ,
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies, Leukemia, vol.24, pp.1686-1699, 2010. ,
Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition, PLoS Biol, vol.7, pp.189-200, 2009. ,
Akt signalling in health and disease, Cell Signal, 2011. ,
Identification and characterization of pleckstrin-homology-domain-dependent and isoenzyme-specific Akt inhibitors, Biochem J, vol.385, pp.399-408, 2005. ,
Mechanisms of action of flavopiridol, Crit Rev Oncol Hematol, vol.38, pp.139-170, 2001. ,
Flavopiridol inhibits NF-kappaB activation induced by various carcinogens and inflammatory agents through inhibition of IkappaBalpha kinase and p65 phosphorylation: abrogation of cyclin D1, cyclooxygenase-2, and matrix metalloprotease-9, J Biol Chem, vol.279, pp.4750-4759, 2004. ,
Mammalian target of rapamycin as a therapeutic target in leukemia, Curr Mol Med, vol.5, pp.653-661, 2005. ,
Serine/threonine phosphatases in the DNA damage response and cancer, Oncogene, vol.29, pp.5977-5988, 2010. ,
Regulation of protein kinase cascades by protein phosphatase 2A, Trends Biochem Sci, vol.24, pp.186-191, 1999. ,
Expressions of four major protein Ser/Thr phosphatases in human primary leukemic cells, Leukemia, vol.13, pp.595-600, 1999. ,
PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect, Leukemia, vol.25, pp.606-614, 2011. ,
Regulation of cell proliferation and survival: convergence of protein kinases and caspases, Biochim Biophys Acta, vol.1804, pp.505-510, 2010. ,
Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5, Blood, vol.111, pp.3742-3750, 2008. ,
P53 transcriptionindependent activity mediates selenite-induced acute promyelocytic leukemia NB4 cell apoptosis, BMB Rep, vol.41, pp.745-750, 2008. ,
Frequent mutations in the p53 gene in human myeloid leukemia cell lines, Blood, vol.79, pp.2378-2383, 1992. ,
Nuclear factor kB as a target for new drug development in myeloid malignancies, Haematologica, vol.92, pp.1224-1229, 2007. ,
Role of hyperforin in the pharmacological activities of, CNS Drug Rev, vol.10, pp.203-218, 2004. ,
Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet, Arzneimittelforschung, vol.55, pp.15-22, 2005. ,
Hypericum perforatum: a 'modern' herbal antidepressant: pharmacokinetics of active ingredients, Clin Pharmacokinet, vol.45, pp.449-468, 2006. ,
Controversies in treatment of AML: case-based discussion, Hematology Am Soc Hematol Educ Program, pp.185-191, 2006. ,
Biochemical, cellular, and pharmacological aspects of the multidrug transporter, Annu Rev Pharmacol Toxicol, vol.39, pp.361-398, 1999. ,
Chemotherapy resistance in acute myeloid leukaemia, Best Pract Res Clin Haematol, vol.14, pp.211-233, 2001. ,
Hyperforin inhibits P-gp and BCRP activities in chronic lymphocytic leukaemia cells and myeloid cells, Leuk Lymphoma, vol.48, pp.1587-1599, 2007. ,
Molecular bases of myelodysplastic syndromes: lessons from animal models, J Cell Physiol, vol.219, pp.529-534, 2009. ,
Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice, Blood, vol.115, pp.1406-1415, 2010. ,
The clathrin-binding domain of CALM-AF10 alters the phenotype of myeloid neoplasms in mice, Oncogene, 2011. ,
Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia, Expert Opin Investig Drugs, vol.18, pp.1333-1349, 2009. ,
Novel Inhibitors of AKT: Assessment of a Different Approach Targeting the Pleckstrin Homology Domain, Curr Med Chem, 2011. ,
Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin, Leukemia, vol.19, pp.1760-1767, 2005. ,
NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3), Blood, vol.77, pp.1080-1086, 1991. ,
Effect of eluent pH on HPLC/UV analysis of hyperforin, Phytochem Anal, vol.17, pp.71-77, 2006. ,
Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaBregulated antiapoptotic and cell survival gene products in human multiple myeloma cells, Blood, vol.109, pp.2293-2302, 2007. ,
Mechanisms of differentiation of U937 leukemic cells induced by GM-CSF and 1,25(OH)2 vitamin D3, Leuk Res, vol.15, pp.409-418, 1991. ,
Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, alpha1,25-dihydroxyvitamin D3 or 12-Otetradecanoyl phorbol-13-acetate, Leuk Res, vol.22, pp.537-547, 1998. ,
TGF-beta 1-stimulated adhesion of human mononuclear phagocytes to fibronectin and laminin is abolished by IFN-gamma: dependence on alpha 5 beta 1 and beta 2 integrins, Exp Cell Res, vol.222, pp.209-217, 1996. ,
Interferons inhibit tumor necrosis factor-alpha-mediated matrix metalloproteinase-9 activation via interferon regulatory factor-1 binding competition with NF-kappa B, J Biol Chem, vol.277, pp.35766-35775, 2002. ,